Latest News

As part of our ’25 at 25’ series, we look back at The SHINE trial, which was the first randomised controlled trial to assess the length of treatment needed for children with TB.
In the early 2000s, very few of the 25 million people living with HIV in sub-Saharan Africa were on antiretroviral therapy. Our '25 at 25' series explores how our clinical trials helped widen access to HIV treatment.
HIV vaccines tested in PrEPVacc fail to reduce infections
Our ‘25 at 25’ series examines how the Unit’s work has evaluated and helped improve clinical trial monitoring practices.
Researchers from the MRC Clinical Trials Unit at UCL and our partner institutions will showcase their latest work on HIV trials at the 25th International AIDS Conference and International Workshop on Pediatrics & HIV.